Managing repeated screening for known CPE carriers: once positive always positive? Siddharth Mookerjee, Eleonora Dyakova, Frances Davies, Kathleen Bamford,

Slides:



Advertisements
Similar presentations
1. 2 Global Travel – who goes? 3 Global Links of NDM to the UK Kumarasamy et al., Lancet Infect Dis :
Advertisements

REALM project update MRSA and KPC January 26, 2011 Michael Lin, MD MPH on behalf of REALM co-investigators.
APIC Chapter 13 Journal Club April 15, 2015
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
A pilot assessment of the impact and resource implications of a 48-hour ward-based stewardship team review on antibiotic use in a tertiary centre Nicola.
© Aurora Health Care, Inc. Carbapenem Resistant Enterobacteriaceae The Alphabet Soup of Infection Prevention Aurora Health Care System Infection Prevention.
RESULTS INTRODUCTION METHODS CONCLUSION  Extended spectrum beta-lactamases producing Enterobacteriacae (ESBLPE) have become a major cause of hospital-acquired.
Moving forward together infection prevention and control and AMR Rose Gallagher Nurse Advisor Infection Prevention and Control Royal College of Nursing.
Division of Public Health CRE Surveillance and Prevention of Transmission in Healthcare Settings Gwen Borlaug, CIC, MPH Coordinator, Healthcare-Associated.
The role of the English Surveillance Programme on Antimicrobial Use & Resistance in improving stewardship Susan Hopkins Consultant Infectious Diseases.
CARBAPENEM RESISTANT ENTEROBACTERIACEAE: RISK FACTORS AND ROLE OF EXTENDED CARE FACILITIES A. Makarem, MD; P. Alvarez, MD; T. Chou, MPH, CIC; M. Kulkarni,
Carbapenemase- Producing Carbapenem-Resistant Enterobacteriaceae Nicole Hearon, HAI Epidemiologist Surveillance and Investigation Division Indiana State.
RESULTS INTRODUCTION METHODS CONCLUSION  Since the early 90’s Enterococcus faecium resistant to Glycopeptides (GRE) have emerged in several French hospitals.
Detecting CPE: time to throw away those agar plates?
30mm 10mm logo safe area 10mm logo safe area EDITING NOTES All copy must stay within the content limit guidelines. Any image added to a slide with text.
European approaches to MDR- GNR prevention and control Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust Blog:
The role of PHE’s AMRHAI Reference Unit Professor Neil Woodford Antimicrobial Resistance & Healthcare Associated Infections (AMRHAI) Reference Unit © Crown.
Containing CRE spread Jon Otter, PhD FRCPath Scientific Director, Healthcare, Bioquell Research Fellow, King’s College London
Part III Key Strategies for Combating Resistance.
How I deal with an outbreak? Prof Bertrand SOUWEINE Medical ICU Clermont-Ferrand France ISICEM March 2009.
CRE/CPE/CRO: Demystifying the microbiology and opportunities for whole genome sequencing Jon Otter, PhD FRCPath Imperial College Healthcare NHS Trust 
CPE, CRE, CPO and CRABs! Jon Otter, PhD FRCPath Imperial College Hospitals NHS Trust Blog:
Screening for vancomycin-resistant enterococci (VRE) Why bother?
Objectives Methods Results Conclusions Contact 64
Alison Holmes, Jonathan Otter
The growing dangers around CPE
CRE Surveillance and Prevention
Introduction and Purpose References and Acknowledgements
Are Vitek2 system and E-test relevant and reliable for determining susceptibility to temocillin? Visée C.1, Frippiat F1, Descy J.2, Meex C.2, Melin P.2,
CRE prevalence among patients with no prior history of carriage
Professor Alan Johnson Department of HCAI & AMR
Introduction Materials and methods Results Conclusions
Research Challenges and Experiences
Screening for CPE: sensitivity of serial admission screens
CPE screening: seek and ye shall find!
Using a stand-alone air disinfection unit to reduce the risk from contaminated aerosols from heater-cooler units used for cardiothoracic surgery Eleonora.
Who’s carrying CPE? Universal admission screening in London
REDUCED RATES OF VANCOMYCIN RESISTANT ENTEROCOCCI (VRE) COLONIZATION
IPC – new, novel, and exciting
GNBSI Can we really halve GNBSIs? Jon Otter, PhD FRCPath
Bacteraemia in Buckinghamshire Healthcare NHS Trust
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
Counting the cost of controlling an outbreak of CPE: an economic evaluation Jonathan A. Otter,1,2 Philip Burgess,3 Frances Davies,2 Siddharth Mookerjee,2.
Nine decades of antibiotics: how many years of antibiotic resistance?
The ‘bed location lottery’: the MDRO status of the prior bed occupant affects the risk of acquisition Jon Otter, PhD Scientific Director, Healthcare, Bioquell.
Promiscuous plasmids? Scaling infection control implications of horizontal spread of carbapenemase genes between species Siddharth Mookerjee, Frances Davies,
Using the Toolkit to build a CPE policy
Main modes of transmission CPE
Carbapenemase-Producing Enterobacteriacea
Risk factors for carbapenem-resistant Enterobacteriaceae (CRE) carriage at the time of hospital admission Siddharth Mookerjee,1 Eleonora Dyakova,1 Frances.
Carbapenem-resistant Gram-negative bacteria
Changes to 10A NCAC 41A May 5, 2018.
Chapter 1: Introduction to Multidrug – Resistant Organisms
Cost utility of alternative Carbapenemase
Fast and expensive or cheap and slow
Overseas travel and antibiotic use are more important than community demographics or measures of social and material deprivation in predicting ESBL colonization.
Measuring and improving compliance with risk-factor based CPE admission screening Siddharth Mookerjee,1 Kate Martin, 1 Itziar Atucha-Zambrano, 1 Rebecca.
To screen or not to screen for VRE in immunocompromised patients?
CPE: coming to a hospital near you!
“Can I swab your rectum please
Carbapenemase-Producing Enterobacteriacea
Detecting and managing CPE outbreaks: seek and you shall find
Hospital cleaning and disinfection: we can do better!
The management of CPE outbreaks panel
Implementing innovation when financial times are hard
“Bug of the month “ Pseudomonas aeruginosa (Gram negative bacilli)
To Dip Or Not To Dip – Improving the management of Urinary Tract Infection in older people Improving Patient Safety & Care 6th Feb 2019 Continuous Learning,
Microbiology and Infection prevention and control
Jennifer Henderson1,2, Holly Ciesielczuk1, Shona Nelson2 & Mark Wilks1
Before an outbreak - what to do after first MDR Gram-negatives enter your hospital? Jon Otter, PhD FRCPath Imperial College London
Presentation transcript:

Managing repeated screening for known CPE carriers: once positive always positive? Siddharth Mookerjee, Eleonora Dyakova, Frances Davies, Kathleen Bamford, Tracey Galletly, Eimear Brannigan, Alison Holmes, Jonathan Otter Siddharth Mookerjee, MPH Imperial College Healthcare NHS Trust Siddharth.mookerjee@imperial.nhs.uk This presentation has two aims How do we manage screening for CPE as per the PHE guidance Does the theory – once positive always positive for CPE stand Add contact details

Carbapenemase-producing Enterobacteriaceae (CPE): ‘triple threat’ Resistance Rapid spread Mortality CPE poses a triple threat – organisms are highly resistant, they lead significant increase in mortality, and they spread rapidly

CPE reported to PHE’s reference lab Latest ESPAUR 2014 report - Can clearly see the dramatic increase in CPE cases reported to PHE, from under 200 cases in 2009, to over 1600 in 2014 ESPAUR 2015.

CPE prevention & control Hand hygiene Cleaning / disinfection Contact precautions Active screening Antibiotic stewardship These are all the interventions you can throw at CPE Focus of this talk is active screening for CPE Action - Make all the same colour, apart from active screening Otter et al. Clin Microbiol Infect 2015;21:1057-1066.

CPE screening recommendations Guidelines to prevent the spread of CPE recommend screening to detect asymptomatic carriers.1-3 Public Health England (PHE) issued a Toolkit to prevent the spread of CPE, which includes recommendations for risk-factor based screening of all admissions.4 PHE recommend that patients ‘at-risk’ are screened on three separate occasions, each separated by 48 hours: An inpatient in a hospital abroad An inpatient in UK hospital which has problems CPE spread Previous positive case Wilson et al. J Hosp Infect 2016 in press. Otter et al. Microbiol Infect 2015; 21:1057-1066. Tacconelli et al. Clin Microbiol Infect 2014; 20 Suppl 1:1-55. Public Health England. CPE Toolkit. 2013. PHE toolkit recommends a risk factor based approach to CPE screening, specifically to detect asymptomatic carriers, 3 screens separated by 48 hours Specify the risk factors noted by PHE

Local screening strategy Risk-factor based admission screening of all admissions Universal admission screening in ‘high-risk’ specialties Weekly screening in high-risk specialties, and around known carriers. Contact tracing screening for newly identified cases. Admission screening and contact tracing was performed using three screens, each separated by 48 hours. Weekly screening was performed using a single screen. Rectal swabs were requested, some perineal swabs were sent; both were included in the analysis. Risk factors = Patients with overnight hospitalisation in any hospital (including our own readmissions) with in the past 12 months, and overseas residents. Universal screening: ICU, renal, vascular and haematology in-patient wards.

New CPE cases, April 2014 – June 2016 Universal risk-factor based admission screening was introduced in June 2015 to extend screening that was being performed in high-risk specialties. The majority of cases are from screens, without evidence of clinical infection. Here is the trend in new CPE case, Apr 14 onwards, we at Imperial initiated universal and risk factor based screening in Jun-15, can see a spike in new cases, vast majority from screens, without evidence of clinical infections

Aims Determine CPE carriage rate on admission. Establish the value of serial admission screens to confirm negative CPE carriage status. Explore the pattern of apparent carriage to test a “once positive, always positive” approach. We undertook a piece of work with the following aims 1), 2), 3) Taking into account all CRE screens from Jun to Dec 15

Methods For admission screens, the timelines applied to evaluate the benefit of serial screens were: 1st screen at <24 hours, 2nd between 25-72 hours, and 3rd between 73-120 hours. Screening swabs plated onto chromogenic media (ColorexTM mSuperCARBATM, E&O Laboratories, UK). Suspicious colonies were tested for antimicrobial susceptibility (EUCAST disc diffusion), and carbapenemase gene detection by PCR (Xpert® Carba-R, Cepheid Inc, USA). CPE identified locally and PCR- suspicious isolates sent to the PHE AMRHAI reference unit for confirmation. Standard methods based on chromogenic medium, PCR locally to confirm carrier status and ref lab referal for confirmation

Methods – bacterial groups Gram-negative bacteria Enterobacteriaceae *Resistant Enterobacteriaceae CPE The biggest group here is the GNB, a sub-set of that…. Worth noting that since isolates grown on chromogenic media, all GNR are resistant, the resistant Enterobacteriaceae are just the highly resistant ones * Resistant to ertapenem, meropenem, temocillin or tazocin.

Methods Data was de-duplicated separately for each time-point. Carriage rate at the three screening points was tested for a significant trend-change using logistic regression analysis for each organism-group, accounting for repeated measure where relevant. This work was considered a service evaluation, and did not require an application to the NHS Research Ethics Service. Data de-duplicated for each time-point, significant change in trend analysed using logistic regression and repeated measures logistic regression analysis, work done as part of a service evaluation

Carriage rate by screening time-point * What did we find? 11, 378 Patients screened at time point 1, time point 2, time point 3, significant change in trend only in Enterobacteriaceae * = significant trend-change: p<0.05.

Carriage rate by screening time-point (patients who received all 3 screens) Just check this with ED Small number of patients - 221 Patients who have had all 3 screens, with 3 screens taken at the specific time points, no significant change in trend n=221. No significant trend-change for any of the organism-groups: p>0.05.

Carriage rate for patients who received 3 screens at any time-point * * * 1509 Patients who have had 3 screens, where 3 screens need not fall at specific time points, i.e. consecutive, significant change in trend in GN, Enterobacteriaceae and resistant Entero In contrast the most interesting slide is the one for patients who received 3 screens at any time-points n=1509. * = significant trend-change: p<0.05.

Once positive, always positive? Of 51 that had least three screens, 24 (47.1%) had a ‘+-+’ pattern. 60 / 64 (93.8%) patients had at least one negative surveillance culture during their hospital stay (excluding 6 patients with a single positive screen). Serial CPE screens from 70 patients who were found to be CPE positive by screening cultures during June – December 2015. Red = positive. Green = negative. Moving onto the 2nd aim, once positive for CPE, always positive? Lets see… We map out serial CPE screens from 70 patients who were found to be CPE positive from screening culture, red = pos, green = negative 47%, almost half of the 51 who had atlleast 3 screens, had a + - + pattern Then go through whats on screens and then give example of line 4.. Not sure if we should believe the negative screens

Discussion The carriage rate on admission was low (0.5%), consistent with the few other studies in the UK 1 Serial admission screens add little value in detecting cases. We are not aware of any other evaluation of the performance of serial admission screens for CPE. Rectal swabs as effective as stool samples, and 2x as effective at detecting resistant Enterobacteriacaea than perineal.2,3 A negative CPE screen is not to be trusted for known carriers, as found in other studies.4,5 Otter et al. J Antimicrob Chemother. 2016; 71(10) Lerner et al. Antimicrob Agents Chemother 2013;57:1474-1479. Dyakova et al. IPS 2015, and submitted. O’Fallon et al. Clin Infect Dis 2009;48:1375e1381. Feldman et al. Clin Microbiol Infect 2013;19:E190eE196. Low carriage rate of 0.6% Little value in serial admission screening Rectal swabs as effective as stool samples Don’t trust negative CPE screen for known carriers

Recommendations Serial screening to confirm negative CPE carriage status when admission screening and contact tracing has ceased. Weekly screening in high-risk areas and around all patients with known CPE. Regular screening of long-stay patients for carriage of resistant Gram-negative bacteria should be considered. “Once positive, always positive” approach. We ceased serial screening to confirm negative CPE carriage status We continue weekly screening in high-risk areas known to have CPE patients Regular screening of long-stay patients for carriage of GNB should be considered Once pos always pos!

Simple, stark, sobering sums 0.5% x 186,393 = 932 (!) 0.1% x 186,393 = 186 0.1% x 15.892m* = 15,892 Taking our carriage rate of CPE – 0.5% and applying it to our yearly patient admissions, means we can see close to 900 CPE positive patients 0.1% which is a conservative estimate, apply that, and its 186 0.1 is the conservative estimate, applying that to all NHS hospitals, 16,000 pos patients, currently reporting around1600, 10 fold underestimate of CPE positive patients * Admissions to NHS acute hospitals, Financial Year 14/15. NHS Confederation, Key Statistics on the NHS,

Managing repeated screening for known CPE carriers: once positive always positive? Siddharth Mookerjee, Eleonora Dyakova, Frances Davies, Kathleen Bamford, Tracey Galletly, Eimear Brannigan, Alison Holmes, Jonathan Otter Siddharth Mookerjee, MPH Imperial College Healthcare NHS Trust Siddharth.mookerjee@imperial.nhs.uk